Clyburn Frank 4
4 · Revolution Medicines, Inc. · Filed Aug 7, 2024
Insider Transaction Report
Form 4
Clyburn Frank
Director
Transactions
- Award
Common Stock
2024-08-05+6,932→ 6,932 total - Award
Stock Option (Right to Buy)
2024-08-05+27,744→ 27,744 totalExercise: $42.48Exp: 2034-08-05→ Common Stock (27,744 underlying)
Footnotes (2)
- [F1]Includes 6,932 restricted stock units.
- [F2]The option becomes exercisable as it vests and the shares subject to the option vest with respect to 1/36 of the shares subject thereto on each monthly anniversary of August 5, 2024, subject to the reporting person's continued employment or service relationship with the Company on each such vesting date.